The objective of this study was to examine the quality of life in patients with Parkinson's disease (PD) in a community-based sample (n ס 228 patients) using a Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) as a measure. Associations to the variables age, age at onset, duration, c
Self estimated quality of life in monogenetic Parkinson's disease
✍ Scribed by Susanne Gräber; Inga Liepelt-Scarfone; Theresa Brüssel; Katherine Schweitzer; Thomas Gasser; Daniela Berg
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 247 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The purpose of this study was to assess quality of life (QoL) of patients with idiopathic Parkinson's disease (IPD). The Parkinson's Disease Questionnaire (PDQ‐39) was compared with an individualized QoL tool: the Schedule for Evaluation of Individual Quality of Life Direct Weighting (S
## Abstract We evaluated the relationship between upper extremity (UE) and lower extremity (LE) motor impairments in Parkinson's disease (PD) to overall disability and quality of life (QoL) measures. A total of 639 patients who were diagnosed with idiopathic PD were administered the Unified Parkins
## Abstract Our objective was to identify determinants of health‐related quality of life (HRQoL) in a cohort of Brazilian patients with Parkinson's disease (PD). Patients were evaluated by means of the Hoehn and Yahr staging (H&Y), Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and Englan
## Abstract ## Objective This study investigated the predictive value of various coping processes for the psychological and disease specific aspects of health‐related quality of life (HRQoL) in Parkinson's disease (PD). ## Method Cross‐sectional study of 85 participants with PD using the Ways of
## Abstract The impact of Parkinson's disease on quality of life may vary depending on age at onset. We investigated the effect of age at onset on quality of life in a large Parkinson's disease population (n = 426) using a disease‐specific rating scale (PDQ‐39) and with careful adjustment for confo